Quantitative, spatial resolution of the epigenetic field effect in prostate cancer.

Full Abstract

BACKGROUND: Although a field effect in which transformed cells extend beyond morphologically evident tumor has been proposed in cancer, little direct evidence exists as to its magnitude and spatial resolution. We tested this hypothesis using molecular techniques to detect epigenetic changes in the primary tumor and surrounding tissues. METHODS: Ex vivo core biopsies, each spaced approximately 1 mm apart, were generated from 37 unique prostatectomy samples. The first core biopsy was confirmed to be histologically positive for cancer, and the subsequent biopsies were confirmed to be histologically negative. The methylation ratio of GSTP1, APC, RARbeta2, and RASSF1A were measured for all of the 159 cores. RESULTS: No field effect, defined as absence of epigenetically transformed cells, for GSTP1 was observed whereas APC, RARbeta2, and RASSF1A showed a field effect up to 3 mm from the malignant core in three prostatectomy samples. Furthermore, for each case, different patterns of the field effect were observed. The field effect appeared most pronounced with RARbeta2. In 11 prostatectomy samples in which a second focus of cancer was identified, cells harboring RARbeta2 methylation extended a large distance away from the primary tumor in one sample. Bisulfite sequencing of RARbeta2 confirmed the presence of epigenetic aberrations. CONCLUSIONS: This study quantifies previous observations of methylation in histologically negative samples and provides important assessment of field effects based on epigenetic events in cancer. These molecular approaches set the stage for consideration of such data in prospective trials for assessment of surgical margins and prediction of recurrence.

Author information

Author/s: Mehrotra, Jyoti (J); Varde, Shobha (S); Wang, Haiying (H); Chiu, Hsiling (H); Vargo, Janet (J); Gray, Karen (K); Nagle, Raymond B (RB); Neri, Jaclyn R (JR); Mazumder, Abhijit (A);

Affiliation: Veridex LLC, a Johnson and Johnson Company, Warren, New Jersey, USA.

Journal and publication information

Publication Type: Journal Article

Journal: The Prostate (Prostate), published in United States. (Language: eng)

Reference: 2008-Feb; vol 68 (issue 2) : pp 152-60

Dates: Created 2007/12/26; Completed 2008/03/13;

PMID: 18058812, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Adenomatous Polyposis Coli Protein - genetics
Base Sequence
Biopsy
DNA Methylation
DNA, Neoplasm - genetics
Epigenesis, Genetic - genetics
Glutathione S-Transferase pi - genetics
Humans

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Adenomatous Polyposis Coli Protein (0) ; DNA, Neoplasm (0) ; RASSF1 protein, human (0) ; Receptors, Retinoic Acid (0) ; Tumor Markers, Biological (0) ; Tumor Suppressor Proteins (0) ; retinoic acid receptor beta (0) ; GSTP1 protein, human (EC 2.5.1.18) ; Glutathione S-Transferase pi (EC 2.5.1.18)

These are the most related articles currently in our database: